Loss‐of‐function mutations in Seipin cause congenital generalized lipodystrophy type 2 (CGL2), characterised by severe loss of adipose tissue, hypertriglyceridemia, fatty liver and insulin resistance.19 Here, BSCL2 is linked to congenital generalized lipodystrophy type 2.